Skip to main content
Barbara Ajazi on Muck Rack

Barbara Ajazi

As seen in: JAMA Network
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barbara

Contact Barbara, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

FLOT vs CROSS Among Patients With Pathological Complete Response in Esophageal Adenocarcinoma

|
By Kiu Chou, Lorenzo Giorgi, Nadia Maria Guidozzi, Ewen Griffiths, Sheraz R. Markar, Riadh Salem, Stijn Vanstraelen, Helena Gielen, Johnny Moons, Philippe Nafteux, Jelle P. Ruurda, Richard van Hillegersberg, Xavier Benoit D’Journo, Simone Giacopuzzi, Maria Bencivenga, Lars M. Schiffmann, Christiane J. Bruns, Giovanni Maria Garbarino, Andrea Pansa, Silvia Basato, Ophélie Bacoeur-Ouzillou, Caroline Gronnier, Suzanne S. Gisbertz, Jessie A. Elliott, Kirsty Cole, youssef ibrahim, Philip H. Pucher, Martin L. Skogar, Jakob Hedberg, Éloïse Bonnin, Julie Veziant, Guillaume Piessen, Agnese Carresi, Silvia Battaglia, Riccardo Rosati, Fredrik Klevebro, Magnus Nilsson, Misha D. P. Luyer, Rita Alfieri, Carlo Castoro, Mark Van Berge Henegouwen, Sam Alhayo, Ella Seabourne, Femke E. Lammes, Alban Todesco, Alice Collizzolli, Barbara Ajazi, Aram Abu Hejleh, Sofie P. G. Henckens, Rakesh Ahmed, Nithiesh Loganathan, Chanakya Anand, Fahad Murad, Grard A. P. Nieuwenhuijzen, Lars van de Sanden
| JAMA Network Verified
Key Points Question Does survival after pathological complete response differ between 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) and the Chemoradiotherapy for Oesophageal Cancer Followed by Surgery Study protocol (CROSS)? Findings In this cohort study of 297 patients with pathological complete response after neoadjuvant therapy, perioperative FLOT was associated with significantly better overall and disease-free survival compared with CROSS.
Open in Who Shared View Duplicates (2) Issue with article?
See all 1 articles